Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies
戈利木单抗在中重度活动性溃疡性结肠炎患者中的药代动力学和暴露-反应关系:来自 2/3 期 PURSUIT 诱导和维持研究的结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjw133
Adedokun, Omoniyi J; Xu, Zhenhua; Marano, Colleen W; Strauss, Richard; Zhang, Hongyan; Johanns, Jewel; Zhou, Honghui; Davis, Hugh M; Reinisch, Walter; Feagan, Brian G; Rutgeerts, Paul; Sandborn, William J